سعر ميراميركس 400مجم 5 اقراص 2026

Moxifloxacin 400 mg film-coated tablets, pack of 5, by Pharmed Healthcare (listed with Abbott Laboratories), Egypt.

• Community-acquired pneumoniaPopulation: Adults (18 years and older)DailyMed (U.S. National Library of Medicine)
• Uncomplicated skin and skin structure infectionsPopulation: Adults (18 years and older)DailyMed (U.S. National Library of Medicine)
• Complicated skin and skin structure infectionsPopulation: Adults (18 years and older)DailyMed (U.S. National Library of Medicine)

• Most common adverse reactions (>=3%): nausea, diarrhea, headache and dizziness.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Known hypersensitivity to moxifloxacin or other quinolones.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Boxed warning: fluoroquinolones have been associated with disabling and potentially irreversible serious adverse reactions including tendinitis and tendon rupture, peripheral neuropathy and CNS effects, and may exacerbate muscle weakness in myasthenia gravis (avoid). Reserve for acute bacterial sinusitis and bronchitis exacerbations only when no alternative exists.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• QT prolongation: avoid in known QT prolongation, uncorrected hypokalemia, and with class IA or III antiarrhythmics; also reported: hypersensitivity reactions, aortic aneurysm/dissection, Clostridioides difficile-associated diarrhea, blood glucose disturbances and photosensitivity.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Multivalent cation products (Mg/Al antacids, sucralfate, iron, zinc, multivitamins, didanosine)Decrease moxifloxacin absorption; take moxifloxacin at least 4 hours before or 8 hours after.DailyMed (U.S. National Library of Medicine)
• Class IA and class III antiarrhythmics and other QT-prolonging drugsAdditive QT prolongation; avoid concomitant use.DailyMed (U.S. National Library of Medicine)
• Warfarin; antidiabetic agents; NSAIDsFluoroquinolones may enhance warfarin effects (monitor INR); dysglycemia with antidiabetic agents (monitor glucose); NSAIDs may increase the risk of CNS stimulation and convulsions.DailyMed (U.S. National Library of Medicine)

• No available human data establish a drug-associated risk; based on animal studies moxifloxacin may cause fetal harm (no malformations at 0.24-2.5 times clinical exposure, but decreased fetal weight and other effects at higher doses).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• It is not known whether moxifloxacin is present in human milk; it is excreted in rat milk. Weigh the benefits of breastfeeding against the mother's need for the drug and potential adverse effects on the infant.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

English text not available for this section.